Berman Capital Advisors, LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 154 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.4%.

Quarter-by-quarter ownership
Berman Capital Advisors, LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$3,000
+200.0%
133
+202.3%
0.00%
Q2 2021$1,000
-93.3%
44
-87.1%
0.00%
-100.0%
Q1 2021$15,000
+650.0%
340
+672.7%
0.00%
Q4 2020$2,000
+100.0%
440.0%0.00%
Q3 2020$1,000440.0%0.00%
Q2 2020$0440.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 523,280$10,722,00712.30%
RTW INVESTMENTS, LP 17,687,772$362,422,4487.65%
Logos Global Management LP 1,975,000$40,467,7505.40%
ACUTA CAPITAL PARTNERS, LLC 362,000$7,417,3804.97%
New Leaf Venture Partners, L.L.C. 118,242$2,422,7793.11%
MAVERICK CAPITAL LTD 5,629,970$115,358,0852.60%
Ghost Tree Capital, LLC 295,000$6,044,5501.99%
Frazier Life Sciences Management, L.P. 1,403,013$28,747,7361.91%
Ikarian Capital, LLC 654,726$13,415,3351.61%
Boxer Capital, LLC 1,466,051$30,039,3851.60%
View complete list of ROCKET PHARMACEUTICALS INC shareholders